Why the study?
Does EPO reduce deaths in patients with chronic heart failure and anemia?
Does EPO reduce deaths in patients with chronic heart failure and anemia?
The decision to use an agent to treat anemia in heart failure should be made on a case-by-case basis, as it is yet to be determined if treating anemia improves outcomes.
Many patients with chronic heart failure also have anemia, an association that has been increasingly recognized in recent years. Whether treating anemia will improve outcomes in patients with heart failure has yet to be determined, however. The decision to use an agent to treat anemia in heart failure should be made on a case-by-case basis.
No takes yet. Share an insight, caveat, or question.
Iyengar et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: